» Articles » PMID: 21460299

Are We Ready for Novel Detection Methods to Treat Respiratory Pathogens in Hospital-acquired Pneumonia?

Overview
Journal Clin Infect Dis
Date 2011 Apr 5
PMID 21460299
Citations 36
Authors
Affiliations
Soon will be listed here.
Abstract

Hospital-acquired pneumonia represents one of the most difficult treatment challenges in infectious diseases. Many studies suggest that the timely administration of appropriate, pathogen-directed therapy can be lifesaving. Because results of culture and antimicrobial susceptibility testing can take 48 h or longer, physicians currently rely on clinical, epidemiological, and demographic factors to assist with the choice of empiric therapy for antibiotic-resistant pathogens. At present, a number of rapid molecular tests are being developed that identify pathogens and the presence of genetic determinants of antimicrobial resistance (eg, GeneXpert [Cepheid], ResPlex [Qiagen], FilmArray [Idaho Technologies], and Microarray [Check-Points]). In this review, the potential impact that molecular diagnostics has to identify and characterize pathogens that cause hospital-acquired bacterial pneumonia at an early stage is examined. In addition, a perspective on a novel technology, polymerase chain reaction followed by electrospray ionization mass spectrometry, is presented, and its prospective use in the diagnosis of pneumonia is also discussed. The complexities of the pulmonary microbiome represent a novel challenge to clinicians, but many questions still remain even as these technologies improve.

Citing Articles

Solid and Suspension Microarrays for Microbial Diagnostics.

Miller S, Karaoz U, Brodie E, Dunbar S Methods Microbiol. 2024; 42:395-431.

PMID: 38620236 PMC: 7172482. DOI: 10.1016/bs.mim.2015.04.002.


Evaluation of BioFire® FilmArray® Pneumonia Panel in Bronchoalveolar Lavage Samples From Immunocompromised Patients With Suspected Pneumonia.

Li-Geng T, Zervou F, Aguero-Rosenfeld M, Zacharioudakis I Cureus. 2023; 15(4):e38024.

PMID: 37228561 PMC: 10205050. DOI: 10.7759/cureus.38024.


Trends in Molecular Diagnosis of Nosocomial Pneumonia Classic PCR vs. Point-of-Care PCR: A Narrative Review.

Balan A, Bodolea C, Tranca S, Hagau N Healthcare (Basel). 2023; 11(9).

PMID: 37174887 PMC: 10177880. DOI: 10.3390/healthcare11091345.


The dynamic lung microbiome in health and disease.

Natalini J, Singh S, Segal L Nat Rev Microbiol. 2022; 21(4):222-235.

PMID: 36385637 PMC: 9668228. DOI: 10.1038/s41579-022-00821-x.


Urgent need for a rapid microbiological diagnosis in critically ill pneumonia.

Martinez Sagasti F, Calle Romero M, Rodriguez Gomez M, Alonso Martinez P, Garcia-Perrote S Rev Esp Quimioter. 2022; 35 Suppl 1:6-14.

PMID: 35488817 PMC: 9106203. DOI: 10.37201/req/s01.02.2022.


References
1.
Kollef M . Moving towards real-time antimicrobial management of ventilator-associated pneumonia. Clin Infect Dis. 2007; 44(3):388-90. DOI: 10.1086/510595. View

2.
Wang X, Ginocchio C . Automation of the BD GeneOhm methicillin-resistant Staphylococcus aureus assay for high-throughput screening of nasal swab specimens. J Clin Microbiol. 2009; 47(5):1546-8. PMC: 2681855. DOI: 10.1128/JCM.00114-09. View

3.
Huletsky A, Giroux R, Rossbach V, Gagnon M, Vaillancourt M, Bernier M . New real-time PCR assay for rapid detection of methicillin-resistant Staphylococcus aureus directly from specimens containing a mixture of staphylococci. J Clin Microbiol. 2004; 42(5):1875-84. PMC: 404602. DOI: 10.1128/JCM.42.5.1875-1884.2004. View

4.
Tenover F, Weigel L, Appelbaum P, McDougal L, Chaitram J, McAllister S . Vancomycin-resistant Staphylococcus aureus isolate from a patient in Pennsylvania. Antimicrob Agents Chemother. 2003; 48(1):275-80. PMC: 310200. DOI: 10.1128/AAC.48.1.275-280.2004. View

5.
Esperatti M, Ferrer M, Theessen A, Liapikou A, Valencia M, Saucedo L . Nosocomial pneumonia in the intensive care unit acquired by mechanically ventilated versus nonventilated patients. Am J Respir Crit Care Med. 2010; 182(12):1533-9. DOI: 10.1164/rccm.201001-0094OC. View